In collaboration with Payame Noor University and Iran Neuropsychology Association

Document Type : Original article

Authors

1 PhD student in Psychology, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

2 Assistant Professor, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

3 Professor, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

Abstract

Purpose: The purpose of this study is to determine the effectiveness of combined cognitive-behavioral and neurofeedback therapy on the relapse reduction in stimulant substance abusers with depressive symptoms. Method: A semi-experimental study was conducted with a pre-test-post-test design and a two-month follow-up period. All male substance abusers who were referred to the Sepahan substance abuse treatment center in 1st district of Tehran in 1402 formed the statistical population of the study. With the available and purpose-based sampling method, 36 people were selected from among substance abusers who met the criteria for entering the research and randomly divided into 2 groups of 18 people (combined treatment group for stimulant substance abusers, control group for stimulant substance abusers) were replaced. Data collection was done with demographic information checklist-researcher-made form, revised depression questionnaire and substance abuse relapse risk questionnaire. Data analysis was done with statistical methods, testing the assumptions of parametric statistics and analysis of variance with repeated measurements with statistical software Spss-v26. Findings: The results showed that the combined treatment in the subjects of the experimental group of two groups of stimulant drug abusers is effective in reducing the relapse rate and its dimensions (intention to use, emotional problems, compulsion to use, lack of control and positive expectation of drug use). (P<0.05).  Conclusion: This study further clarified the role of psycho-behavioral structures in substance abuse patients and reveals the necessity of using combined treatment approaches (cognitive

Keywords

Main Subjects

Abooie B, S. M., Mardani T. (2023). Comparison of the Effectiveness Combination of CBT and Methadone Therapy wiih MT on Anxiety and Craving Believes in Adolescent. Middle Eastern Journal of Disability Studies.
Albarrán-Cárdenas, L., Silva-Pereyra, J., Martínez-Briones, B. J., Bosch-Bayard, J., & Fernández, T. (2023). Neurofeedback Effects on EEG Connectivity among Children with Reading Disorders: I. Coherence. Applied Sciences, 13(5), 2825.
Bashkirtsev, O., Zimba, O., & Gasparyan, A. Y. (2023). PSYCHOLOGICAL INTERVENTIONS IN THE TIME OF CRISIS. Anti-Aging Eastern Europe, 2(1), 6-8.
Bilevicius, E., Single, A., Bristow, L. A., Foot, M., Ellery, M., Keough, M. T., & Johnson, E. A. (2018). Shame mediates the relationship between depression and addictive behaviours. Addictive behaviors, 82, 94-100.
Ekendahl, M., & Karlsson, P. (2022). A matter of craving–An archeology of relapse prevention in Swedish addiction treatment. International Journal of Drug Policy, 101, 103575.
Fede, S. J., Kisner, M. A., Dean, S. F., Kerich, M., Roopchansingh, V., Diazgranados, N., & Momenan, R. (2023). Selecting an optimal real‐time fMRI neurofeedback method for alcohol craving control training. Psychophysiology, e14367.
Ghaffarzadeh Razaghi MR, H. (2022). Comparison Between the Effectiveness of Cognitive-Behavioral Therapy, Fluoxetine Therapy and Combination Method on Improving Premature Ejaculation Disorder in Opioid Addicts. Health Psychology [Internet], 11(41):83–96. doi:http:..etiadpajohi.ir.article-1-2577-en.html
Kabisa, E., Biracyaza, E., Habagusenga, J. d. A., & Umubyeyi, A. (2021). Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre. Substance abuse treatment, prevention, and policy, 16(1), 1-12.
Knaus, W. J. (2021). The Cognitive Behavioral Workbook for Anger: A Step-by-step Program for Success: New Harbinger Publications.
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., . . . Wyatt, S. A. (2011). Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Journal of addiction medicine, 5(4), 254-263.
Li, J., Wang, R., He, J., Wang, L., & Li, L. (2023). Comparison of the effect of hostility on the level of depression of drug addicts and non-addicts and the mediating role of sense of life meaning between them. BMC psychiatry, 23(1), 350.
Liese, B. S., & Beck, A. T. (2022). Cognitive-behavioral therapy of addictive disorders: Guilford Publications.
Magill, M., Kiluk, B. D., & Ray, L. A. (2023). Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate? Substance Abuse and Rehabilitation, 1-11.
Mohammadi Jochi N, N. M. (2020). Getting to know the effects of drugs, stimulants and hallucinogens. Tehran: Mirmah Publications.
N, G. (2021). The effectiveness of alpha.theta neurofeedback in individuals with dependent to morphine and neurofeedback in drug abuse. In: National conference on physical education and sport science with emphasis on physical activity limitation during the covid-19 virus prevalence. Tehran.
Ogai, Y., Haraguchi, A., Kondo, A., Ishibashi, Y., Umeno, M., Kikumoto, H., . . . Aso, K. (2007). Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan. Drug and alcohol dependence, 88(2-3), 174-181.
Prior, K., Mills, K., Ross, J., & Teesson, M. (2017). Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug and alcohol review, 36(3), 317-324.
Russo, G. M., Smith, S., & Sperandio, K. R. (2023). A meta‐analysis of neurofeedback for treating substance use disorders. Journal of Counseling & Development, 101(2), 143-156.
Shakerinasab, M., Azimzadeh, T. N., Rostami, T., & Parsa, N. M. (2022). The Effectiveness of Cognitive-Behavioral Therapy Based on Marlatt's Model on Craving and Addiction Quitting Self-Efficacy in Patients under Treatment with Methadone.
Soleimani, E., Nooeipour, R., Khosravian, B., Hasani, A. H., & Hoseinian, S. (2019). Effectiveness of Neurofeedback in Drug Use Craving and Attentional Bias to Drug-related Stimulants in Substance Abusers. Scientific Quarterly Research on Addiction, 12(48), 61-82.
Souilm, N. (2023). Equine-assisted therapy effectiveness in improving emotion regulation, self-efficacy, and perceived self-esteem of patients suffering from substance use disorders. BMC Complementary Medicine and Therapies, 23(1), 363.
Srivastava, A. B., Sanchez‐Peña, J., Levin, F. R., Mariani, J. J., Patel, G. H., & Naqvi, N. H. (2021). Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula‐bed nucleus of the stria terminalis resting‐state functional connectivity. Alcoholism: Clinical and Experimental Research, 45(8), 1596-1606.
Waite, M. R., Heslin, K., Cook, J., Kim, A., & Simpson, M. (2023). Predicting substance use disorder treatment follow-ups and relapse across the continuum of care at a single behavioral health center. Journal of substance use and addiction treatment, 147, 208933.
ZAREI, S. (2022). Parental Marital Conflict And Adolescents Drug Abuse Tendency: The Moderated Model Of Depression And Mindfulness.
Zech, H. G., Reichert, M., Ebner-Priemer, U. W., Tost, H., Rapp, M. A., Heinz, A., . . . Deserno, L. (2022). Mobile data collection of cognitive-behavioral tasks in substance use disorders: where are we now? Neuropsychobiology, 81(5), 438-450.